Usana Health Sciences Inc (USNA) SEC Filing 8-K Material Event for the period ending Monday, October 11, 2021

Usana Health Sciences Inc

CIK: 896264 Ticker: USNA

View differences made from one to another to evaluate Usana Health Sciences Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Usana Health Sciences Inc.


Assess how Usana Health Sciences Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Usana Health Sciences Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Usana Health Sciences Inc provided additional information to their SEC Filing as exhibits

Ticker: USNA
CIK: 896264
Form Type: 8-K Corporate News
Accession Number: 0001157523-21-001196
Submitted to the SEC: Tue Oct 12 2021 4:31:34 PM EST
Accepted by the SEC: Tue Oct 12 2021
Period: Monday, October 11, 2021
Industry: Medicinal Chemicals And Botanical Products
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: